Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. (Q51005301)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 June 2011
edit
Language Label Description Also known as
English
Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis.
scientific article published on 12 June 2011

    Statements

    Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit